Intravenous (IV) Solution Manufacturing in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Intravenous (IV) Solution Manufacturing Market Research Report | Life Sciences | Medical Supplies | Oct 2015

Free flowing: The consistent need for IV solutions has kept industry growth steady

IBISWorld’s Intravenous (IV) Solution Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Market Share of Companies
Baxter International Inc. Baxter International Inc. market share
Hospira Inc. Hospira Inc. market share
Industry Statistics & Market Size
Annual Growth 10-15
Annual Growth 15-20
Purchase to read more
Purchase to read more
Industry Analysis & Industry Trends

Whether for delivering anesthesia or nutrients, the Intravenous (IV) Solution Manufacturing industry provides hospitals with an array of IV solutions. Since the industry relies mainly on downstream demand from hospitals, the number of people with health insurance plays a critical role in determining demand for IV solutions. Forthcoming changes to the nation's healthcare system under the Patient Protection and Affordable Care Act of 2010 are anticipated to increase the number of insured Americans over the next five years. In turn, hospital demand is projected to rise and help support demand for IV solutions.... purchase to read more

Industry Report - Industry Investment Chapter

The Intravenous Solution Manufacturing industry exhibits a moderate level of capital intensity. Using depreciation as a proxy for capital expenditures and wage as a measure of labor costs, IBISWorld estimates that for every $1.00 spent on labor, industry manufacturers spend $0.25 on capital in 2015. This marks a decrease from $0.27 in 2010. Wages have typically accounted for 8-11% of revenue, a figure that accounts for the specialized nature of labor in the industry. It is also a figure that has declined to 9.8% in 2015. As wages' portion of revenue continues to fall, depreciation and consequently capital investments continues to remain constant at 2.4%... purchase to read more


Industry ProductsRelated ReportsTable of Contents

What is the Intravenous (IV) Solution Manufacturing Industry?

Companies in this industry primarily engage in manufacturing substances that may be infused directly into a vein using a venous access device. Intravenous (IV) solutions may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement. Solutions specifically for animals are excluded from this industry.

Industry Products
CrystalloidsColloidsBlood productsOxygen-carrying solutions
Industry Activities
Manufacturing crystalloid solutionsManufacturing colloid solutionsManufacturing blood productsManufacturing oxygen-carrying products

View Sample
Select Clients